Immune response of subjects at high risk of hepatitis B to a new genetically engineered hepatitis B vaccine administered in low doses by the intradermal route.

Source:http://linkedlifedata.com/resource/pubmed/id/2288216

Download in:

View as

General Info

PMID
2288216